These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11405340)

  • 1. The role of chaperone-assisted folding and quality control in inborn errors of metabolism: protein folding disorders.
    Gregersen N; Bross P; Andrese BS; Pedersen CB; Corydon TJ; Bolund L
    J Inherit Metab Dis; 2001 Apr; 24(2):189-212. PubMed ID: 11405340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired folding and subunit assembly as disease mechanism: the example of medium-chain acyl-CoA dehydrogenase deficiency.
    Bross P; Andresen BS; Gregersen N
    Prog Nucleic Acid Res Mol Biol; 1998; 58():301-37. PubMed ID: 9308370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein misfolding and degradation in genetic diseases.
    Bross P; Corydon TJ; Andresen BS; Jørgensen MM; Bolund L; Gregersen N
    Hum Mutat; 1999; 14(3):186-98. PubMed ID: 10477427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones.
    Kim PS; Arvan P
    Endocr Rev; 1998 Apr; 19(2):173-202. PubMed ID: 9570036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein misfolding disorders: pathogenesis and intervention.
    Gregersen N
    J Inherit Metab Dis; 2006; 29(2-3):456-70. PubMed ID: 16763918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators.
    Muntau AC; Leandro J; Staudigl M; Mayer F; Gersting SW
    J Inherit Metab Dis; 2014 Jul; 37(4):505-23. PubMed ID: 24687294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein misfolding in conformational disorders: rescue of folding defects and chemical chaperoning.
    Leandro P; Gomes CM
    Mini Rev Med Chem; 2008 Aug; 8(9):901-11. PubMed ID: 18691147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.
    Tao YX; Conn PM
    Physiol Rev; 2018 Apr; 98(2):697-725. PubMed ID: 29442594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and cellular modifiers of oxidative stress: what can we learn from fatty acid oxidation defects?
    Olsen RK; Cornelius N; Gregersen N
    Mol Genet Metab; 2013; 110 Suppl():S31-9. PubMed ID: 24206932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4D imaging of protein aggregation in live cells.
    Spokoini R; Shamir M; Keness A; Kaganovich D
    J Vis Exp; 2013 Apr; (74):. PubMed ID: 23608881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prefoldin Promotes Proteasomal Degradation of Cytosolic Proteins with Missense Mutations by Maintaining Substrate Solubility.
    Comyn SA; Young BP; Loewen CJ; Mayor T
    PLoS Genet; 2016 Jul; 12(7):e1006184. PubMed ID: 27448207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity.
    Fan JQ
    Biol Chem; 2008 Jan; 389(1):1-11. PubMed ID: 18095864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein quality control: chaperones culling corrupt conformations.
    McClellan AJ; Tam S; Kaganovich D; Frydman J
    Nat Cell Biol; 2005 Aug; 7(8):736-41. PubMed ID: 16056264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.
    Duncan EJ; Cheetham ME; Chapple JP; van der Spuy J
    Subcell Biochem; 2015; 78():243-73. PubMed ID: 25487025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellularly located misfolded glycoprotein hormone receptors associate with different chaperone proteins than their cognate wild-type receptors.
    Mizrachi D; Segaloff DL
    Mol Endocrinol; 2004 Jul; 18(7):1768-77. PubMed ID: 15105436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular chaperones in protein quality control.
    Lee S; Tsai FT
    J Biochem Mol Biol; 2005 May; 38(3):259-65. PubMed ID: 15943899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folding and assembly of viral membrane proteins.
    Doms RW; Lamb RA; Rose JK; Helenius A
    Virology; 1993 Apr; 193(2):545-62. PubMed ID: 8460475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological chaperones: a new twist on receptor folding.
    Morello JP; Petäjä-Repo UE; Bichet DG; Bouvier M
    Trends Pharmacol Sci; 2000 Dec; 21(12):466-9. PubMed ID: 11121835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel treatments in neurometabolic diseases: the importance of chaperones].
    Perez B
    Rev Neurol; 2018 Jun; 66(s02):S43-S46. PubMed ID: 29876912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of molecular and chemical chaperones on protein folding.
    Welch WJ; Brown CR
    Cell Stress Chaperones; 1996 Jun; 1(2):109-15. PubMed ID: 9222596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.